Alnylam Pharmaceuticals (NASDAQ:ALNY) Rating Increased to Buy at StockNews.com
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “buy” rating in a report issued on Thursday. A number of other research analysts have also recently weighed in on the stock. Scotiabank dropped their price objective on shares of Alnylam Pharmaceuticals from $310.00 to […]
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “buy” rating in a report issued on Thursday. A number of other research analysts have also recently weighed in on the stock. Scotiabank dropped their price objective on shares of Alnylam Pharmaceuticals from $310.00 to […]
